Caris Life Sciences (CAI) Research & Development (2024 - 2026)

Caris Life Sciences' Research & Development history runs 3 years deep, the most recent figure standing at $45.0 million for Q1 2026.

• On a quarterly basis, Research & Development rose 13.09% year-over-year to $45.0 million in Q1 2026; TTM through Mar 2026 was $140.8 million, a 22.26% decrease from a year earlier, with the FY2025 full-year figure at $101.6 million, down 33.43% from the prior year.
• Research & Development improved to $45.0 million in Q1 2026 per CAI's latest filing, from $31.8 million in the prior quarter.
• Across five years, Research & Development topped out at $65.8 million in Q4 2024 and bottomed at $21.6 million in Q3 2025.
• The 3-year median for Research & Development is $39.3 million (2024), against an average of $40.2 million.
• Across the five-year window, Research & Development tumbled 51.6% in 2025 and rose 13.09% in 2026, its largest moves.
• Year by year, Research & Development stood at $65.8 million in 2024, then tumbled by 51.6% to $31.8 million in 2025, then soared by 41.44% to $45.0 million in 2026.
• Per Business Quant, the three latest CAI Research & Development figures stand at $45.0 million (Q1 2026), $31.8 million (Q4 2025), and $21.6 million (Q3 2025).